SUMMARY Thrombin-induced aggregation and serotonin release were markedly enhanced in platelets from spontaneously hypertensive rats (SHR) when compared with those from normotensive Wistar-Kyoto rats (WKY). Since phosphoinositides are involved in calcium-mediated platelet responses, the metabolism of these lipids was investigated in SHR and WKY by using 32 P-labeled quiescent platelets. In unstimulated cells, both the rate and extent of 32 P incorporation into individual inositol-containing phospholipids and phosphatidic acid were identical in SHR and WKY. This finding suggests that the pool size and basal turnover of phosphoinositides did not differ between the two strains. In contrast, early thrombin-induced phosphoinositide metabolism, when monitored as changes in [
F REE cytosolic calcium plays an important role
in the development of tension in vascular smooth muscle, and hence arteriolar resistance, and may be closely related to the development of primary hypertension (see References 1 and 2 for recent reviews). Altered calcium handling by membranes (reviewed in Reference 3), as well as enhanced intracellular free calcium content, has been reported in various cell types of essentially hypertensive patients and spontaneously hypertensive rats (SHR). 4 " 9 However, the mechanism by which intracellular calcium levels become elevated in cells from hypertensive subjects remains unknown. In these subjects, platelets have been shown to display an increased sensitivity toward a variety of agonists as measured by the cell physiological responses (e.g., shape change, aggregation, release reaction, thromboxane formation). 10 " 15 Since platelet responses are mainly controlled by Ca 2+ influx, Ca 2+ mobilization, or both, 16 these circulating cells appear to be an attractive model for studying the reactivity of cells from hypertensive subjects with respect to calcium metabolism.
A wide range of cell-activating substances that involve Ca 2+ mobilization in the expression of the cellular response are known to act by stimulating the metabolism of inositol-containing membrane lipids: phosphatidylinositol (PI), phosphatidylinositol 4-phosphate (PIP), phosphatidylinositol 4,5-bisphosphate (PIP 2 ; see Reference 17 for review). The agonistmediated breakdown of PIP 2 by phospholipase C is considered the earliest event initiating cell activation 498 HYPERTENSION VOL 10, No 5, NOVEMBER 1987 in the overall alteration of cell Ca 2+ handling and responsiveness observed in hypertensive subjects. To gain a further understanding of the mechanism(s) accounting for the Ca 2+ -related hyperreactivity of cells from hypertensive subjects, we studied phosphoinositide metabolism in washed platelets from SHR, either in their resting state or after thrombin stimulation. This comparison was performed by measuring the variations in 32 P-labeled lipids following platelet incubation with [ 32 P] orthophosphate. Aggregation and serotonin release reaction were also measured. The results were compared with those obtained from washed platelets isolated from normotensive control rats of the Wistar-Kyoto strain (WKY).
Materials and Methods Animals
Male SHR of the Okamoto strain and normotensive WKY were obtained from CERJ (St. Berthevin, France) and were studied at 12 to 15 weeks of age. Systolic arterial blood pressure, measured by the tailcuff method, was 190 ± 3 and 122 ± 2 (SEM) mm Hg for SHR and WKY, respectively {n= 15 rats per strain).
Preparation of 32 P-Labeled and [ 3 H]Serotonin-Labeled Washed Platelets
Blood was withdrawn from the abdominal aorta of rats under light ether anesthesia into 10% (vol/vol) 170 mM trisodium citrate/130 mM citric acid/4% dextrose as anticoagulant. Platelet-rich plasma was obtained by centrifugation at 230 g for 15 minutes at room temperature and was further centrifuged at 120 g for 7 minutes to sediment contaminating red and white blood cells. Platelets in platelet-rich plasma (generally 4-5 ml/animal; i.e., -10 9 cells/ml) were labeled with either 32 P by incubation at 37 °C for 2 hours with P 2 P]orthophosphate, 3 ^Ci/10 8 cells (1 mCi/ml; Amersham, Buckinghamshire, UK) or 3 H by incubation at 37 °C for 5 minutes with 10" 6 M serotonin containing [ 3 H]serotonin, 1 /xCi/10 9 cells (19.8 Ci/mmol; Amersham). Labeled platelets were isolated by centrifugation at 400 g for 15 minutes and resuspended in an equivalent volume of Ca 2+ -free Tyrode's buffer (NaCl, 137 mM; KC1, 2.6 mM; NaHCO 3 , 12 mM; MgCl 2 , 0.9 mM, glucose, 5.5 mM; EGTA, 1 mM; gelatin, 0.25%, pH 6.5). Platelets were then washed twice in Tyrode's buffer by centrifugation at 400 g for 15 minutes. The final platelet pellet was resuspended in a Ca 2+ -free Tyrode's/HEPES buffer (NaCl, 137 mM; KC1, 2.6 mM; MgCl 2 , 0.9 mM; glucose, 5.5 mM; HEPES, 5 mM; gelatin, 0.25%, pH 7.4). All steps following platelet labeling were performed at room temperature. Platelet suspensions from SHR and WKY were adjusted to equal concentrations (2-4 10 s cells/ml) and, unless otherwise specified, were incubated for a 60-minute equilibration period at 37 °C before experimentation. This procedure was judged to yield fully "rested" platelets on the basis of negligible To measure the parameters under study, platelet suspensions (0.4 ml) were placed into aggregometer tubes, stirred for 2 minutes (1000 rpm) at 37°C in the presence of 1.3 mM CaCl 2 (unless otherwise specified), and then exposed to thrombin or buffer (control).
For [
3 H]serotonin-labeled platelets, 10~* M imipramine was added with CaCl 2 to prevent serotonin reuptake during the release reaction. Tracings of platelet shape change and aggregation were obtained by recording light transmission throughout all experiments.
Assays
Following the addition of thrombin (or buffer), platelet serotonin release was determined by assaying the appearance of [ 3 H]serotonin in the platelet-free suspension, as described previously. 23 Thrombin-induced serotonin release was expressed as the percentage of maximum release obtained by stimulating the platelet suspensions with thrombin (5 U/ml) for 5 minutes. The amount of radioactivity in the supernatants of unstimulated platelet suspensions (i.e., spontaneous release) was subtracted from all values. Throughout the experiments, spontaneous release never exceeded 7% of the maximum serotonin release and no difference was noted between platelets of SHR and WKY.
To measure 32 P-labeled lipids following the platelet reaction in aggregometer cuvettes, 32 P-labeled platelets were transferred to tubes containing 3.75 volumes of ice-cold chloroform/methanol/concentrated HC1 (20:40:1, vol/vol/vol) to terminate the reaction. Lipids were then extracted and analyzed as previously described. 24 The various inositol lipids and PA were separated by one-dimensional thin-layer chromatography on oxalate-impregnated silica gel plates (article 5715; Merck), Darmstadt, West Germany) using chloroform/acetone/methanol/glacial acetic acid/water (40:15:13:12:8, per volume)." The 32 P-labeled lipids were localized by autoradiography and scraped off the plates, and their radioactivity was counted by scintillation. For identification, standard phospholipids (Sigma Chemical, St. Louis, MO, USA) were submitted to chromatography along with the platelet extracts and visualized by idoine vapor.
Statistical Analysis
One animal was used per experiment, and each measurement was performed in duplicate. Variability was expressed as the means ± SEM, and tests of significance were performed using the unpaired Student's / test. represents the shape change of platelets from disks to spheres while an increase in light transmission reflects platelet aggregation. After a short (20 seconds) period of stimulation by low concentrations of thrombin (up to 0.5 U/ml), the aggregation of platelets of SHR could be readily observed while only the shape change of platelets of WKY was visible. When platelet suspensions from both strains were allowed to aggregate, the velocity of aggregation was higher in SHR than in WKY (91 ± 3 vs 61 ± 6 mm/min; n = 8, p < 0 . 0 1 , with thrombin, 0.3 U/ml).
Results

Thrombin-induced Physiological Responses
Serotonin Release
Preliminary experiments indicated that [ 3 H] serotonin incorporation as well as spontaneous and thrombin-induced serotonin release did not change whether platelet-rich plasma was incubated for 2 hours at 37 °C and pH] serotonin was added for the last 5 minutes (so that the total length of incubation was similar to that for the 32 ] serotonin release by platelets stimulated with thrombin, 0.3 U/ml, showed an increase within the first 30 to 60 seconds and a plateau thereafter ( Figure 2A ). Figure 2 also shows that, at all times studied, from 10 seconds up to 2 minutes, platelets of SHR exhibited release values about 2.5 times higher than the respective values produced by platelets of WKY. When studied as a function of the dose of thrombin, the [ 3 H]serotonin release (after 20 seconds of stimulation) was barely detectable for thrombin concentrations below 0.1 U/ml, but it increased in a dosedependent manner between 0.2 and 0.5 U/ml and reached a maximum of 70 to 80% at thrombin, 1 U/ml ( Figure 2B ). When stimulated by thrombin concentrations of 0.2 to 0.5 U/ml, platelets of SHR released significantly more [ 3 H] serotonin than did platelets of WKY; the difference was no more significant at thrombin, 1 U/ml (see Figure 2B ).
P-Labeling of Lipids in Unstimulated Platelets: Kinetics and Distribution
Under the experimental conditions used, five major lipids incorporated the label: PIP 2 , PIP, PI, PA, and an as yet unidentified inositol-containing glycerophospholipid designated X by Tysnes et al. 26 in human platelets. The chromatographic separation of 32 P-labeled lipids extracted from rat platelets (not shown) VOL 10, No 5, NOVEMBER 1987 was similar to that published by Tysnes et al., 26 who used the same solvent system for the separation of phospholipids from human platelets.
The 32 P-labeling of rat platelet lipids was first studied as a function of incubation time with [ 32 P]orthophosphate. Figure 3 shows that the 32 P radioactivity associated with the lipids increased with time up to 90 to 120 minutes and, except for PI, reached a plateau thereafter. 32 P incorporation into X (not represented for reasons of clarity) exhibited the same pattern as PIP. There was no difference between SHR and WKY in the rate of 32 P-labeling of all platelet lipids.
Preliminary experiments with either rat strain (not shown) revealed that, following preparation of washed platelets, a 1-hour incubation period (see Materials arid Methods) allowed [ 32 P]PI to be near isotopic equilibrium without affecting the 32 P values associated with the other lipids. Thereafter, all 32 P-labeled lipids (except for PI) remained stable for at least 1 more hour (i.e., the time required for our experimental design). All further experiments were therefore performed using such an equilibration period.
The distribution of 32 P into lipids of unstimulated platelets from SHR and WKY observed under our experimental conditions is summarized in 
Results are means ± SEM. Values in parentheses represent the percentage of radioactivity associated with each class of lipid over the total lipid-associated radioactivity. Platelets were 32 P-labeled by incubating platelet-rich plasma with [ 32 P]orthophosphate for 2 hours.
32 P-labeled platelets were then isolated by washing, and the resulting platelet suspension was further incubated for a 60-minute equilibration period, before analysis of 32 P-labeled lipids (see Materials and Methods). PI = phosphatidylinositol; PIP = PI 4-phosphate; PIP 2 = PI 4,5-bisphosphate; PA = phosphatidic acid; X = unidentified inositolcontaining glycerophospholipid.
Thrombin-Induced 3Z P-Labeled Lipid Changes Figure 4 represents the comparison between SHR and WKY of 32 P-labeled phosphoinositide changes brought about by exposure to thrombin, 0.3 U/ml, for various times. A significant loss (10-15%) of the radioactivity associated with PIP 2 was constantly observed within 20 to 30 seconds after stimulation and was followed by an increased incorporation of the label at longer times. There was no significant difference between SHR and WKY in the extent of the [ 32 32 [P]PA value obtained in unstimulated platelets), [ 32 P]PA increased in a dose-dependent manner up to 0.5 U/ml and reached a plateau thereafter to attain a maximum of about 600% at 1 U/ml ( Figure 5B) . Comparison of the dose-response curves obtained with platelets of SHR and WKY reveals that at concentrations up to 0.5 U/ml the thrombin-induced P 2 P]PA increase was significantly higher (about 1.5 times) in SHR than in WKY (see Figure  5B ). At 0.5 U/ml, although [ (Table 2) .
FiauRE 5. Kinetic (A) and dose-response (B) studies of thrombin-induced phosphatidic acid (PA) formation in platelets of SHR and WKY. 32 P'-labeled washed platelet suspensions from SHR and WKY were stimulated with thrombin (0.3 U/ml) or buffer (control) for the designated times (A) or with various doses of thrombin for 20 seconds (B)
.
Discussion
The present findings demonstrate that, in terms of physiological responses (i.e., aggregation and release reaction), washed platelets of SHR were more reactive than those of WKY. This finding is consistent with previous studies that reported a hyperreactivity of Table 1 ). For the measurements, the platelets were suspended in buffer containing either 0.2 mM EGTA ( -Ca 2 + ) or 1.3 mM CaCl 2 ( + Ca 2 + ) for 2 minutes before thrombin addition (see Materials and Methods). *p<0.01, §p<0.05, compared with values for the WKY calcium-deprived group. tp<0.05, t p < 0.01, compared with values for the WKY calcium-containing group. platelets of SHR to a variety of stimuli, 13 " 15 suggesting a defect distal to membrane receptors. Moreover, our results show that enhanced secretion of serotonin in platelets of SHR could not be accounted for by differences either in the total platelet serotonin content or in the maximum release capacity between the two strains. Since platelet serotonin uptake has been reported to be identical in SHR and WKY, 27 the impaired serotonin secretion we observed in SHR probably is related to abnormalities in calcium influx or mobilization, or both, on stimulation. Since phosphoinositides play an integral role in these mechanisms, their metabolism was investigated in platelets of SHR and WKY.
This end was achieved by using 32 P-labeled and quiescent platelets whose lipids were at isotopic equilibrium. Since resting platelets contain very small quantities of diacylglycerol (DG), 28 they should exhibit very low levels of PA 29 and, hence, of [ 32 P]PA. Such requirements appear to be fulfilled with our experimental design since [ 32 P]PA values were less than 2% of total l a b e l e d lipids (see Table 1 ). Unstimulated platelets of SHR and WKY behaved similarly with respect to both the rate and extent of 32 Plabeling of each lipid (see Figures 3 and Table 1 33 The hypersensitivity of phospholipase C in SHR is likely a reflection of a cellular defect, since the experiments were performed with washed platelets. However, the lasting effect of some circulating substance(s) cannot be excluded.
In platelets, phospholipase C hydrolysis of PIP 2 generates two second messengers, DG and inositol 1,4,5-trisphosphate (IP 3 ). DG stimulates a specific Ca 2+ -activated, phospholipid-dependent protein kinase called protein kinase C (see Reference 34 for review), which phosphorylates specific proteins implicated in platelet degranulation, 33 while IP 3 is believed to be responsible for Ca 2+ mobilization from the dense tubular system. 36 The cellular events activated by DG and IP 3 interact synergistically to trigger rapid and complete platelet responses. 34 -37 It is therefore conceivable that protein kinase C activity would be enhanced in thrombin-stimulated platelets of SHR, in which a hyperactivity of phospholipase C would result in an increased production of both DG and IPj. In support of this hypothesis, a recent article reported an enhanced protein kinase C activity in the supernatant of platelets of adult SHR. 38 On the other hand, more Ca 2+ ions would be mobilized into the cytosol to facilitate stimulation of Ca 2+ -sensitive processes that activate platelets (e.g., phospholipase A 2 ). Finally, the combined actions of DG and IP 3 could render the platelets of SHR hyperreactive with regard to their physiological responses. In this respect, the difference between reactivity of SHR and WKY to thrombin, which was greater when expressed as serotonin release than as [ Several studies have reported elevated resting cytosolic free Ca 2+ levels in platelets from hypertensive persons and SHR.
6 " 9 However, this increase in cytosolic Ca 2+ concentration was abolished when platelets were incubated in the presence of EGTA, providing similar Ca 2+ levels in SHR and WKY. 8 Since thrombin-induced P 2 P]PA formation was shown to be independent of extracellular Ca 2+ in this and other studies, 33 the hyperreactivity of phospholipase C in SHR probably is not a consequence of elevated resting cytosolic free Ca 2+ levels in this strain. In addition to its capacity to mobilize Ca 2+ from internal stores, thrombin also promotes a Ca 2+ influx. 39 Although in the absence of extracellular Ca 2+ , thrombin-induced serotonin release was markedly reduced in both SHR and WKY, platelets of SHR still exhibited an elevated serotonin secretion compared with those of WKY. 13 Taken together these data strongly suggest that, on stimulation with thrombin, a higher Ca 2+ mobilization is likely to be involved in the platelet hyperreactivity of SHR. It is therefore tempting to assume that an impaired activity of phospholipase C (the primary event in platelet activation by thrombin) participates in the enhanced Ca 2+ -dependent physiological responses of platelets of SHR.
The cellular mechanisms underlying the altered activity of platelet phospholipase C from SHR remain to be established. However, our study provides a molecular basis for investigating the mechanisms involved in the signal-transduction processes in platelets of SHR.
